Healthcare -
Biotechnology - NASDAQ - US
$ 1.1401
-2.56 %
$ 103 M
Market Cap
-0.69
P/E
CRBU - STOCK-BASED COMPENSATION
Stock-based Compensation CRBU - Caribou Biosciences, Inc.
13.8 M
LAST VALUE
99.67%
2 YEAR CAGR
0.00%
5 YEAR CAGR
0.00%
10 YEAR CAGR